Nurix Therapeutics, Inc.
NRIXNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $2.94B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $10.15$28.23
- Volume (live)
- -
- Avg. volume (3M)
- 2.18M
Nurix Therapeutics (NRIX) Stock Price & Financial Analysis
Nurix Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $24.78 - $25.49 |
|---|---|
| 52-Week High | $28.23 |
| 52-Week Low | $10.15 |
| Open | $25.22 |
| Volume (last close) | 1.91M |
| Average Volume (3M) | 2.18M |
| Revenue (TTM) | 701.94M |
|---|---|
| Net Income (TTM) | -341.35M |
| Free Cash Flow (TTM) | 369.81M |
| EPS (TTM) | −$3.41 |
| Profit Margin | -48.63% |
| Operating Margin | -51.45% |
| Return on Equity (ROE) | -35.25% |
| Debt to Equity | 0.06 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 2.94B |
|---|---|
| Shares Outstanding | 116.15M |
| Price to Sales (P/S) | 4.19 |
| Price to Book (P/B) | 3.04 |
| EV/EBITDA | 7.46 |
| 50-Day MA | $25.09 |
|---|---|
| 200-Day MA | $19.86 |
| 1-Year Change | +145.29% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Nurix Therapeutics at a Glance
As of the Oct 23, 2026 close, Nurix Therapeutics (NRIX) has a market capitalization of $2.94B. The stock trades at 4.2× sales. Over the trailing twelve months it lost $341.35M on revenue of $701.94M and generated $369.81M of free cash flow. Revenue grew 738.8% year over year.
As of its latest reported balance sheet, it holds $720.24M in cash and securities against $58.14M of debt, a net cash position of $662.10M.
Nurix Therapeutics does not currently pay a dividend.
The share price is up 145.3% over the past year. At $25.34 (the Oct 23, 2026 close) it sits within its 52-week range of $10.15 to $28.23, above its 200-day moving average of $19.86.
Based on 11 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $34.50, 36.1% above the Oct 23, 2026 close.
Frequently Asked Questions About Nurix Therapeutics
What is the current stock price for NRIX?
As of the Oct 23, 2026 close, NRIX stock trades at $25.34. The 52-week range is $10.15–$28.23, with a day range of $24.78–$25.49.
What is the P/E ratio for NRIX?
The P/E ratio (Price-to-Earnings) for NRIX is shown in the Key Statistics section. This valuation metric helps compare Nurix Therapeutics, Inc. to industry peers.
Does NRIX pay dividends?
Nurix Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NRIX?
Based on ratings from 11 professional analysts over the last 90 days, the consensus for NRIX is Buy. The average 12-month price target is $34.50, a 36.1% upside from the Oct 23, 2026 close of $25.34.
What is the market cap of NRIX?
As of the Oct 23, 2026 close, Nurix Therapeutics's market capitalization is $2.94B, classifying it as a mid-cap company. Nurix Therapeutics operates in the Healthcare sector within the Biotechnology industry.